ArticleVaccines2024

Intranasal Prime-Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection.

Muriel Metko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.